Literature DB >> 19543573

Liver biopsies for chronic hepatitis C: should nonultrasound-guided biopsies be abandoned?

J A Flemming1, D J Hurlbut, B Mussari, L C Hookey.   

Abstract

BACKGROUND/
OBJECTIVE: Liver biopsy has been the gold standard for grading and staging chronic hepatitis C virus (HCV)- mediated liver injury. Traditionally, this has been performed by trained practitioners using a nonimage-guided percutaneous technique at the bedside. Recent literature suggests an expanding role for radiologists in obtaining biopsies using an ultrasound (US)-guided technique. The present study was undertaken study to determine if the two techniques produced liver biopsy specimens of similar quality and hypothesized that at our institution, non-US-guided percutaneous liver biopsies for HCV would be of higher quality than US-guided specimens.
METHODS: Liver biopsies from 100 patients with chronic HCV infection (50 consecutive US-guided and 50 consecutive non-US-guided), were retrospectively identified using a hospital histopathology database. All original biopsy slides were coded and prospectively reanalyzed by a single hepatopathologist who was blinded to the technique used in obtaining the biopsy. Additionally, all liver biopsies for chronic HCV infection completed at the centre from 1998 to 2007 were identified and the technique used was recorded. Biopsy quality was determined primarily by the number of complete portal tracts (CPTs) identifiable in the slides. The total length of specimen and the degree of fragmentation were secondary outcome measures.
RESULTS: There was a slight difference observed between the US-guided and non-US-guided groups in mean age (46.3 years versus 42.5 years, respectively; P=0.018) but no differences in sex, presence of cirrhosis, bilirubin, creatinine, international normalized ratio, and grade or stage of disease. Biopsies obtained using the US-guided technique produced higher quality specimens than the non-US-guided technique based on our primary outcome of number of CPTs in the biopsy (11.8 versus 7.4; P<0.001). US-guided specimens also were longer (24.4 mm versus 19.7 mm; P=0.001), had less fragmentation (P=0.016), and a higher overall histopathological quality assessment (P=0.026) than the non-US-guided biopsies. However, there was no significant difference between the two groups in the ability to grade and stage the disease (96% US-guided versus 90% in non-US-guided (P=0.20). Over a 10-year period, 763 biopsies for chronic HCV infection were identified with an obvious trend toward the increased use of US-guided technique observed at 2% in 1998 to 85% in 2007.
CONCLUSIONS: US-guided liver biopsies for chronic HCV are the most common method of obtaining specimens at the Kingston General Hospital, Kingston, Ontario, and are of higher quality than non-US-guided specimens. However, there is no significant difference in the two techniques in the ability to grade and stage chronic HCV.

Entities:  

Mesh:

Year:  2009        PMID: 19543573      PMCID: PMC2721810          DOI: 10.1155/2009/370651

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  26 in total

Review 1.  Liver biopsy.

Authors:  A A Bravo; S G Sheth; S Chopra
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Complications of percutaneous liver biopsy.

Authors:  Maria Wawrzynowicz-Syczewska; Tomasz Kruszewski; Anna Boron-Kaczmarska
Journal:  Rom J Gastroenterol       Date:  2002-06

Review 3.  Liver biopsy sampling in chronic viral hepatitis.

Authors:  Maria Guido; Massimo Rugge
Journal:  Semin Liver Dis       Date:  2004-02       Impact factor: 6.115

4.  Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

Authors:  J F Cadranel; P Rufat; F Degos
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

5.  Influence of operator experience on performance of ultrasound-guided percutaneous liver biopsy.

Authors:  Patrick Chevallier; Frederic Ruitort; Alban Denys; Pascal Staccini; Marie Christine Saint-Paul; Denis Ouzan; Jean Paul Motamedi; Albert Tran; Pierre Schnyder; Jean Noël Bruneton
Journal:  Eur Radiol       Date:  2004-08-13       Impact factor: 5.315

6.  Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease.

Authors:  Guido Colloredo; Maria Guido; Aurelio Sonzogni; Gioacchino Leandro
Journal:  J Hepatol       Date:  2003-08       Impact factor: 25.083

7.  Current liver biopsy practices for suspected parenchymal liver diseases in the United States: the evolving role of radiologists.

Authors:  Terence L Angtuaco; Sunil K Lal; Geraldine D Banaad-Omiotek; Syed S A Zaidi; Colin W Howden
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

8.  Statement on outpatient percutaneous liver biopsy.

Authors:  W H Jacobs; S B Goldberg
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

9.  Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies.

Authors:  Robert P Myers; Andrew Fong; Abdel Aziz M Shaheen
Journal:  Liver Int       Date:  2008-05       Impact factor: 5.828

10.  Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies.

Authors:  F Piccinino; E Sagnelli; G Pasquale; G Giusti
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

View more
  4 in total

1.  Who should be performing liver biopsies?

Authors:  C N Ghent
Journal:  Can J Gastroenterol       Date:  2009-06       Impact factor: 3.522

2.  Imaging-guided Parenchymal Liver Biopsy: How We Do It.

Authors:  Gopal R Vijayaraghavan; Sheehan David; Myriam Bermudez-Allende; Hussain Sarwat
Journal:  J Clin Imaging Sci       Date:  2011-06-15

3.  Practice of percutaneous needle autopsy; a descriptive study reporting experiences from Uganda.

Authors:  Janneke A Cox; Robert L Lukande; Sam Kalungi; Koen Van de Vijver; Eric Van Marck; Ann M Nelson; Asafu Munema; Yukari C Manabe; Robert Colebunders
Journal:  BMC Clin Pathol       Date:  2014-12-03

Review 4.  Searching cause of death through different autopsy methods: A new initiative.

Authors:  Abhishek Das; Ranadip Chowdhury
Journal:  J Family Med Prim Care       Date:  2017 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.